These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 18453626
21. Fine epitope mapping within the pathogenic thyroglobulin peptide 2340-2359: minimal epitopes retaining antigenicity across various MHC haplotypes are not necessarily immunogenic. Hatzioannou A, Alevizaki M, Carayanniotis G, Lymberi P. Immunology; 2012 Mar; 135(3):245-53. PubMed ID: 22098450 [Abstract] [Full Text] [Related]
22. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. Vasu C, Dogan RN, Holterman MJ, Prabhakar BS. J Immunol; 2003 Jun 01; 170(11):5511-22. PubMed ID: 12759428 [Abstract] [Full Text] [Related]
23. Immunogenetic aspects of human thyroglobulin-reactive T cell lines and hybridomas. Krco CJ, Gores A, David CS, Kong YM. J Immunogenet; 1990 Dec 01; 17(6):361-70. PubMed ID: 2096180 [Abstract] [Full Text] [Related]
24. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression. Fuller BE, Okayasu I, Simon LL, Giraldo AA, Kong YM. Clin Immunol Immunopathol; 1993 Oct 01; 69(1):60-8. PubMed ID: 7691454 [Abstract] [Full Text] [Related]
25. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice. Flynn JC, Fuller BE, Giraldo AA, Panos JC, David CS, Kong YC. J Autoimmun; 2001 Aug 01; 17(1):7-15. PubMed ID: 11488633 [Abstract] [Full Text] [Related]
26. New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Kong YC, David CS. Int Rev Immunol; 2000 Aug 01; 19(6):573-85. PubMed ID: 11129116 [Abstract] [Full Text] [Related]
27. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice. Karras E, Yang H, Lymberi P, Christadoss P. J Autoimmun; 2005 Jun 01; 24(4):291-6. PubMed ID: 15927791 [Abstract] [Full Text] [Related]
28. Suppression in experimental autoimmune thyroiditis: the role of unique and shared determinants on mouse thyroglobulin in self-tolerance. Nabozny GH, Simon LL, Kong YC. Cell Immunol; 1990 Nov 01; 131(1):140-9. PubMed ID: 1699671 [Abstract] [Full Text] [Related]
29. Experimental autoimmune thyroiditis (EAT) induced by the thyroglobulin peptide (2596-2608): influence of H-2 and non H-2 genes. Verginis P, Carayanniotis G. Autoimmunity; 2004 Nov 01; 37(6-7):529-33. PubMed ID: 15621581 [Abstract] [Full Text] [Related]
30. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. Characterization of thyroiditis-inducing T cell lines and clones derived from thyroid lesions. Sugihara S, Fujiwara H, Shearer GM. J Immunol; 1993 Jan 15; 150(2):683-94. PubMed ID: 7678281 [Abstract] [Full Text] [Related]
31. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YC. Cell Immunol; 2004 Jun 15; 229(2):79-85. PubMed ID: 15474522 [Abstract] [Full Text] [Related]
32. The cellular basis for the Ia restriction in murine experimental autoimmune thyroiditis. Williams WV, Kyriakos M, Sharp GC, Braley-Mullen H. Cell Immunol; 1987 Nov 15; 110(1):35-45. PubMed ID: 3499988 [Abstract] [Full Text] [Related]
33. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Kong YC, Flynn JC, Wan Q, David CS. Autoimmunity; 2003 Nov 15; 36(6-7):397-404. PubMed ID: 14669947 [Abstract] [Full Text] [Related]
34. Induction of murine thyroiditis by a non dominant E(k)-restricted peptide of human thyroglobulin. Karras E, Carayanniotis G, Lymberi P. Immunology; 2003 Apr 15; 108(4):556-61. PubMed ID: 12667218 [Abstract] [Full Text] [Related]
35. H-2E(k) expression influences thyroiditis induction by the thyroglobulin peptide (2495-2511). Chronopoulou E, Carayanniotis G. Immunogenetics; 1993 Apr 15; 38(2):150-3. PubMed ID: 7683308 [No Abstract] [Full Text] [Related]
36. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus. Fedoseyeva EV, Tam RC, Orr PL, Garovoy MR, Benichou G. J Exp Med; 1995 Nov 01; 182(5):1481-91. PubMed ID: 7595218 [Abstract] [Full Text] [Related]
37. Participation of Vbeta13(+) and Vbeta1(+) T cells in transfer thyroiditis after activation of mouse thyroglobulin-primed T cells by superantigen staphylococcal enterotoxin A. Wan Q, Kita M, Flynn JC, Panos JC, Motte RW, Davies TF, Giraldo AA, David CS, Kong YC. Cell Immunol; 2001 Nov 01; 213(2):149-57. PubMed ID: 11831877 [Abstract] [Full Text] [Related]
38. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. Gangi E, Vasu C, Cheatem D, Prabhakar BS. J Immunol; 2005 Jun 01; 174(11):7006-13. PubMed ID: 15905543 [Abstract] [Full Text] [Related]
39. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS. J Autoimmun; 2009 Jun 01; 33(3-4):239-46. PubMed ID: 19822405 [Abstract] [Full Text] [Related]
40. Characterization of the in vitro murine T-cell proliferative responses to murine and human thyroglobulins in thyroiditis-susceptible and -resistant mice. Simon LL, Krco CJ, David CS, Kong YM. Cell Immunol; 1985 Aug 01; 94(1):243-53. PubMed ID: 3874704 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]